ELLISON MARK JASON HEATH sold 8.3% of their position (1.81K shares) of OPIANT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $36.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/5/2023ACC: 0001385508-23-000013
Other
Since Jul 2019
-1.81K
Net shares
Net seller
$36.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.81K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.81K
Price / share
$20.20
Trade value
$36.48K
% of position
8.3%
1/5/2023
21.64K→19.83K
Total
Net shares
−1.81K
Net value
-$36.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2023 | S · Sale | −1.81K | $20.20 | $36.48K | 8.3% | 21.64K | 19.83K |
| Total | −1.81K | -$36.48K | ||||||
Derivative Transactions0
No derivative transactions reported